• CF10–EdU Synergy Drives Telomere Attrition in CRC

  2026-08-21

  Das and colleagues show that the fluoropyrimidine polymer CF10 synergizes strongly with EdU in colorectal cancer models, whereas EdU plus 5FU is only additive. The combination increases EdU incorporation and double-strand breaks, reduces telomere staining, and drives S–G2/M arrest with mitotic catastrophe, revealing a telomere-integrity mechanism beyond conventional thymidylate synthase inhibition.

• Amphotericin B: Designing Mechanism-True Assays

  2026-08-20

  Amphotericin B research is strongest when membrane injury, host signaling, and cytotoxicity are measured as distinct biological layers. This guide presents an assay-design framework that connects fungal membrane sterol interaction with orthogonal viability, permeability, and cytokine readouts.

• Ouabain: Selective Na+/K+-ATPase Inhibitor Workflow

  2026-08-20

  Ouabain provides a clean extracellular perturbation of sodium-potassium pump activity for cell, vessel, and cardiac physiology studies. This workflow connects Na+/K+-ATPase inhibition to calcium handling, microvascular signaling, and heart failure research while emphasizing assay controls, dose selection, and interpretation limits.

• GSK126: From EZH2 Biology to Translation

  2026-08-19

  GSK126 is more than a laboratory EZH2 inhibitor: it is a mechanistic probe for testing how PRC2-driven H3K27me3 influences tumor biology, gene silencing, and viral latency. This thought-leadership article connects EZH2-mutant lymphoma, small cell lung cancer research, and emerging neuroepigenetic evidence with practical guidance for assay design, biomarker strategy, and oncology drug development. It also examines how the astrocyte HIV-latency study expands the translational conversation while emphasizing the limits of cross-domain interpretation.

• Nuclear cGAS, Chk2, and L1 Genome Defense

  2026-08-19

  The reference study identifies a nuclear cGAS–CHK2–TRIM41 pathway that limits LINE-1 retrotransposition by promoting ubiquitination and degradation of the L1 protein ORF2p. Its findings connect DNA damage signaling with posttranslational control of mobile genetic elements, providing a mechanistic framework relevant to genome stability, aging, and cancer research.

• Sitagliptin Phosphate Monohydrate in Metabolic Research

  2026-08-18

  Sitagliptin phosphate monohydrate enables controlled DPP-4 inhibition across enzyme, cell, and metabolic disease workflows. Its strongest use-case is mechanistic separation: researchers can test incretin-dependent glucose regulation alongside the GLP-1-independent intestinal stretch pathway revealed by recent mouse research.

• Palbociclib in Gastric Cancer Assembloid Models

  2026-08-18

  Palbociclib (PD0332991) is a powerful CDK4/6 perturbation tool for studying cell-cycle control in cancer. This article explains how patient-derived gastric assembloids can reveal stromal effects that conventional monoculture assays may conceal.

• FLOT1-FOSL2-EphA2 Axis in AD Neuroinflammation

  2026-08-17

  A 2026 Neuropharmacology study identifies a FLOT1-FOSL2-EphA2 signaling axis that promotes pro-inflammatory microglial polarization through p38/MAPK activation in an APP/PS1 model of Alzheimer’s disease. By combining molecular interaction assays with behavioral analysis, the work connects a lipid-raft scaffold protein to transcriptional regulation and cognitive impairment, providing a mechanistic framework for targeted neuroinflammation studies.

• U-73122: PLC Inhibition for Invasion Assays

  2026-08-17

  Use U-73122 to interrogate phospholipase C signaling across calcium-flux, chemotaxis, and breast-cancer invasion workflows. This practical guide combines dose-finding, pathway controls, assay-specific optimization, and troubleshooting to separate PLC-dependent biology from vehicle, viability, and handling artifacts.

• Metronidazole: OAT3 and Anaerobe Assay Workflows

  2026-08-16

  Metronidazole supports two complementary research strategies: quantitative OAT3 transporter inhibition and controlled studies of anaerobic bacteria and protozoa. This workflow-oriented guide explains stock preparation, uptake assays, susceptibility testing, drug-drug interaction modeling, and practical troubleshooting.

• WP1066: JAK2/STAT3 Assay Workflows

  2026-08-15

  WP1066 provides a cell-permeable way to interrogate JAK2/STAT3 signaling in renal carcinoma, AML, and macrophage-centered regenerative models. This guide translates its pathway activity into practical proliferation, phosphorylation, apoptosis, and scaffold-mechanism assays, with controls and troubleshooting built in.

• 2-NBDG in Sorafenib-Resistant HCC

  2026-08-14

  Sorafenib resistance in hepatocellular carcinoma is shaped by interconnected lipid and nutrient pathways. This thought-leadership article examines how the 2-NBDG Glucose Uptake Assay Kit can add a direct, non-radioactive readout of cellular glucose transporter activity to studies of HNF4A-AS1, DECR1, ferroptosis, and treatment response—while clearly distinguishing a testable metabolic hypothesis from mechanisms already established in the literature.

• Dual-Action Kinase Inhibitors and p38α Dephosphorylation

  2026-08-14

  The reference preprint shows that selected kinase inhibitors can do more than block p38α MAP kinase catalysis: they can also accelerate WIP1-mediated dephosphorylation of the activation loop. Biochemical and X-ray structural data connect this effect to an inhibitor-stabilized kinase conformation that exposes phospho-threonine, suggesting a strategy for improving inhibitor potency and signaling specificity.

• DeferoxamineB in Ferroptosis Workflows

  2026-08-13

  DeferoxamineB makes iron availability a controllable variable in cancer cell assays, helping researchers distinguish iron-dependent lipid damage from copper-driven cytotoxicity. This practical guide connects Deferoxamine to metabolic intervention studies with preparation, dosing, readout, and troubleshooting strategies.

• BML-277 Chk2 Inhibitor Workflows

  2026-08-13

  BML-277 enables controlled interrogation of ATP-competitive Chk2 signaling in biochemical assays and radiation-stressed T-cell models. This practical guide connects target engagement, radiation-induced apoptosis inhibition, and emerging cGAS–Chk2 genome-integrity biology while emphasizing controls, dosing logic, and troubleshooting.

14820 records 1/988 page Next 12345 下5页 Last page